LG
TAK icon

Leuthold Group’s Takeda Pharmaceutical TAK Stock Holding History

Leuthold Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,727
Closed -$278K – 217
2023
Q2 		$278K Hold
17,727
– – 0.04% 180
2023
Q1 		$292K Sell
17,727
-1,011
-5% -$16.1K 0.04% 172
2022
Q4 		$292K Sell
18,738
-398
-2% -$5.56K 0.04% 170
2022
Q3 		$248K Hold
19,136
– – 0.04% 168
2022
Q2 		$269K Buy
+19,136
New +$273K 0.04% 171

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Leuthold Group's TAK Position: Q3 2023 in Review

Leuthold Group sold out of Takeda Pharmaceutical (TAK) in Q3 2023, closing a stake of 17,727 shares — an estimated $278K sold.

Leuthold Group first reported a position in TAK in Q2 2022 and held it in 5 quarters. The position peaked at $292K in Q4 2022. 312 funds tracked by Wall St. Rank hold TAK as of Q3 2023.

  • Leuthold Group reported no remaining Takeda Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Leuthold Group sold 17,727 Takeda Pharmaceutical shares in Q3 2023, an estimated $278K.
  • Leuthold Group first reported a position in Takeda Pharmaceutical in Q2 2022 and held it in 5 quarters.
  • Leuthold Group's Takeda Pharmaceutical position peaked at $292K in Q4 2022.
  • 312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2023.

Based on Leuthold Group's 13F filing for Q3 2023, filed 7 Nov 2023.